Urology Devices Industry worth $46.26 billion by 2030
The report "Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User and Region - Global Forecast to 2030" The global urology devices market is projected to reach USD 46.26 billion by 2030 from USD 34.56 billion in 2025, at a CAGR of 6.0% during the forecast period.
Browse 312 market data Tables and 50 Figures spread through 321 Pages and in-depth TOC on "Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html
The high global prevalence of urological diseases, including benign prostatic hyperplasia, urological malignancies, chronic kidney disease, urinary stone disease, and urinary incontinence, significantly impacts the escalating demand for advanced urological devices. Patients diagnosed with urological cancers requiring surgical intervention are increasingly opting for cutting-edge therapeutic approaches such as robotic-assisted prostatectomy, minimally invasive nephron-sparing techniques, and image-guided endoscopic procedures, which necessitate sophisticated diagnostic and surgical devices. Concurrently, the rising incidence of chronic urological conditions requiring long-term management and monitoring drives continuous demand for innovative diagnostic systems, therapeutic equipment, and patient management solutions. Thus, the compounded effect of increasing disease prevalence, evolving treatment paradigms favoring precision and minimal invasiveness, and the critical need for enhanced diagnostic accuracy has created a compelling demand for technologically advanced and specialized urological devices, which is thereby anticipated to substantially support the sustained growth trajectory of the global urology devices market.
The instruments segment dominated the urology devices market in 2024.
Based on product category, the global urology devices market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the urology devices market in 2024. This dominant segment encompasses the most essential and frequently utilized products, including dialysis equipment, flexible and rigid endoscopes, laser-based lithotripsy systems, endovision, fluid management systems, urodynamic systems, and other instruments. These instruments are universally deployed across acute care hospitals, specialty urology centers, ambulatory surgical facilities, outpatient dialysis clinics, and home healthcare settings. The superior positioning of the instruments segment is attributed to its technological versatility, as different urological procedures often require specialized instruments tailored for specific diagnoses and treatment modalities. Additionally, the expanding sophistication of instrumentation technologies continues to elevate the diagnostic accuracy and therapeutic efficacy of these products. Furthermore, the growing demand for standardized, reliable, and high-performance instruments across healthcare facilities worldwide is expected to sustain the strong market position of this segment in the global urology devices market.
The kidney disease segment was the fastest-growing in the urology devices market, by application, in 2024.
The urology devices market is broadly categorized into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones, and other applications. The urinary incontinence segment is expected to register the fastest growth in the urology devices market, fueled by the increasing burden of lifestyle-related disorders, growing patient preference for minimally invasive treatments, and advancements in continence management technologies such as smart catheters, sacral neuromodulation systems, mid-urethral slings, and electrical stimulation devices. Additionally, expanding access to urological care and the integration of digital monitoring solutions across hospitals, clinics, and home care settings are further supporting this growth.
North America was the largest regional market for urology devices in 2024.
North America, comprising the US and Canada, held the predominant market share in 2024, followed by Europe. This leadership position is attributed to the region's well-established healthcare infrastructure, robust diagnostic and surgical capabilities, and substantial public and private healthcare investments, which collectively drive substantial demand for advanced urological technologies. Furthermore, the concentration of leading device manufacturers, availability of favorable reimbursement policies, and high healthcare expenditure per capita are pivotal in fueling the adoption of premium urology devices. As the volume of complex urological interventions continues to escalate, the corresponding demand for precision instruments and advanced diagnostic equipment intensifies, ensuring sustained growth and technological advancement in the North American urology devices market.
Prominent players in the market are Fresenius Medical Care AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Urology Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
